Could One Test Replace Multiple Leukemia Assays? - Top-Institutions - MDSpire

Could One Test Replace Multiple Leukemia Assays?

Researchers assess whether long-read transcriptome sequencing can streamline B-ALL diagnostics

  • May 29, 2026

  • 3 min

Share

Top Institutions in Pathology

Brief introduction explaining scope and methodology.

  • #1

    Columbia University
    Columbia University

    New York, NY

    Key Differentiators

    • Hematology

  • #2

    Herbert Irving Comprehensive Cancer Center
    Herbert Irving Comprehensive Cancer Center

    New York, NY

    Key Differentiators

    • Hematology

  • #3

    Harvard Medical School
    Harvard Medical School

    Boston, MA

    Key Differentiators

    • Hematology

  • #4

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Hematology

  • #5

    Emory University
    Emory University

    Atlanta, GA

    Key Differentiators

    • Hematology

Original Source(s)

Could One Test Replace Multiple Leukemia Assays?

  • May 29, 2026

Related Content

Why We Made a Mobile Digital Pathology Lab

Todd R. Minnigh and his team created ScanVan to address a problem with rare cancer diagnosis that had a particularly personal significance

Preclinical Study in Mice Addresses a Question: Should RAS Inhibitors Be Given Preemptively?

With recent data that RAS inhibition can improve survival in metastatic pancreatic cancer, the optimization of these agents has become a research priority. Minh Than, MD, PhD, a clinical and research ...

FDA Approves Durvalumab Plus BCG for High-Risk NMIBC

On May 28, 2026, the U.S. Food and Drug Administration (FDA) approved the PD-L1 inhibitor durvalumab (Imfinzi) in combination with bacillus Calmette-Guérin (BCG) for the treatment of adult patients wi...